The “positive” or “negative” label in your blood type refers to a single protein called the D antigen, which either sits on the surface of your red blood cells or doesn’t. If it’s there, you’re Rh-positive; if it’s absent, you’re Rh-negative. About 85% of people worldwide carry this protein, making Rh-positive the more common status. The distinction sounds simple, but it has real consequences for blood transfusions, pregnancy, and possibly even susceptibility to certain infections.
What the D Antigen Actually Is
The Rh system is named after the rhesus monkey, where researchers Karl Landsteiner and Alexander Wiener first identified an agglutinable factor in human blood in 1940 and 1941 using immune sera for rhesus blood.1PubMed Central. A Brief History of Human Blood Groups The D antigen is a protein embedded in the red blood cell membrane, weighing roughly 30 kilodaltons.2PubMed Central. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression When people say “Rh-positive” in everyday conversation, they mean their red blood cells display this D protein. When they say “Rh-negative,” the protein is absent.
D is not the only antigen in the Rh system. There are also C, c, E, and e antigens, all produced by a separate but closely related gene called RHCE. The differences between these antigens come down to tiny variations at just a few amino acid positions. For example, the E and e antigens differ by a single amino acid swap at position 226 of the protein, and C and c differ at a different position.3PubMed Central. The genetics of the Rhesus blood group system – Section: The C/c and E/e antigens But D is by far the most clinically significant of these. It is the most immunogenic antigen after A and B, meaning it’s the one most likely to provoke an immune response in someone who lacks it.4PubMed Central. Fetal–maternal incompatibility in the Rh system
Why Some People Are Negative
The genetic story behind being Rh-negative is surprisingly blunt. Most Rh-negative people don’t carry a broken or silenced version of the gene for the D antigen. They simply don’t have the gene at all. The RHD gene was deleted from one branch of the human lineage during the evolution of hominids, so many modern humans completely lack it.5PubMed Central. The genetics of the Rhesus blood group system If you inherit two copies of this deletion, one from each parent, your red blood cells have no D protein and you type as Rh-negative.
Rh-positive people carry at least one working copy of RHD. Because having the gene is dominant over not having it, you only need one copy to produce enough D antigen to type positive. This means two Rh-positive parents can have an Rh-negative child if both happen to be carriers of the deletion. It also means an Rh-negative parent will always pass the deletion to their children, but the child won’t be Rh-negative unless the other parent contributes a deletion too.
How Common Is Each Type Around the World
The frequency of Rh-negative blood varies dramatically by geography. European populations have the highest rates of the RHD deletion worldwide, and within Europe, the Basque people of northern Spain and southwestern France hold the record, with an RHD deletion frequency of about 47%.6PubMed Central. Sequence diversity of the Rh blood group system in Basques Among Europeans more broadly, deletion frequency is around 43%, while in sub-Saharan African populations it drops to roughly 19%, and in East Asian populations it falls to about 7%.7PubMed Central. Evolutionary genetics of the human Rh blood group system
This geographic pattern has led to speculation about whether natural selection drove the RHD deletion to high frequency in Europeans. After all, being Rh-negative carries a reproductive disadvantage in mixed-Rh couples, which you might expect to push the deletion back down over time. But genetic analysis has found no strong evidence that positive selection drove its rise. The most likely explanation is genetic drift or a founder effect: the deletion reached intermediate frequency by chance in ancestral European populations, and once it got close to 50%, the selective pressure against it weakened enough that random fluctuation could maintain it.7PubMed Central. Evolutionary genetics of the human Rh blood group system
Why the Difference Matters in Transfusion
If you’re Rh-negative and receive Rh-positive blood, your immune system may recognize the D antigen as foreign and produce antibodies against it. This process, called alloimmunization, doesn’t always happen immediately or at all, but the risk is substantial. In a study of Rh-negative patients who received Rh-positive red blood cells, about 14% developed anti-D antibodies within a few weeks.8PubMed Central. Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients Other estimates put the rate much higher over time: nearly 80% of Rh-negative recipients may eventually develop sensitization after receiving Rh-positive blood.4PubMed Central. Fetal–maternal incompatibility in the Rh system
Once those antibodies exist, any future transfusion of Rh-positive blood can trigger a hemolytic transfusion reaction, where the immune system attacks and destroys the incoming red blood cells. This is why blood banks are careful to match Rh status. Rh-negative patients receive Rh-negative blood whenever possible. Rh-positive patients can receive either, since they won’t mount a response against D. In emergency situations where Rh-negative blood isn’t available, clinicians sometimes give Rh-positive blood to Rh-negative patients, particularly in men or older women past childbearing age, accepting the risk of sensitization when the alternative is worse.
The Pregnancy Connection
The most famous clinical consequence of the positive-negative divide involves pregnancy. When an Rh-negative mother carries an Rh-positive baby, small amounts of fetal blood can cross the placenta and enter the mother’s circulation, especially during delivery, miscarriage, or certain procedures. If the mother’s immune system produces anti-D antibodies in response, those antibodies can cross back into the fetus during a subsequent pregnancy and attack fetal red blood cells. This condition, hemolytic disease of the fetus and newborn, can range from mild anemia to severe brain damage or death.
The D antigen is responsible for about 95% of cases of hemolytic disease of the newborn.4PubMed Central. Fetal–maternal incompatibility in the Rh system Before medical intervention existed, this was a significant cause of infant mortality. The discovery that the RHD-positive genetic locus contains two genes, RHD and RHCE, while the RHD gene is deleted in most Rh-negative individuals, eventually allowed fetal Rh genotyping using simple blood tests from the mother, enabling early identification of at-risk pregnancies.9PubMed. Rh proteins: key structural and functional components of the red cell membrane
The preventive treatment is an injection of anti-D immunoglobulin, commonly known by the brand name RhoGAM, given to Rh-negative mothers during pregnancy and shortly after delivery. A controlled trial involving roughly 1,800 women showed that this injection reduced the rate of sensitization to about one-tenth of what would be expected without treatment. The overall failure rate was just 1.7%, and a dose of 100 micrograms proved adequate for routine use.10BMJ. Controlled Trial of Various Anti-D Dosages in Suppression of Rh Sensitization following Pregnancy This intervention has been one of the great successes of preventive medicine, transforming a once-devastating condition into a largely manageable one.
The Gray Area Between Positive and Negative
Blood typing is often presented as a clean binary, but reality has some fuzziness. Some people carry a version of the RHD gene that produces reduced amounts of D antigen on their red blood cells. These “weak D” variants occur in an estimated 0.2% to 1% of people of European descent.11PubMed Central. Weak D and partial D: our experience in daily activity Their red cells test weakly or inconsistently with standard typing reagents, sometimes appearing positive with one test and negative with another.
There are also “partial D” variants, where the D protein is present but structurally altered, missing certain parts of the antigen. People with partial D can sometimes produce anti-D antibodies against the portions of the D antigen they themselves lack, behaving immunologically like Rh-negative people despite testing as positive. Distinguishing weak D from partial D requires molecular testing, and getting it wrong has consequences: a person with partial D who is treated as Rh-positive and receives Rh-positive transfusions could become sensitized.
To complicate things further, the RHCE system continues to grow more complex as researchers identify new variants. Four new antigens were reported in a recent update alone, and hybrid alleles have been found that can cause some samples to cross-react with anti-D reagents, leading to potential mistyping.12PubMed. The Rh blood group system: RHCE update None of this typically affects patients directly, but it keeps transfusion medicine laboratories on their toes.
What Do the Rh Proteins Actually Do
You might reasonably ask why any of these proteins exist on red blood cells in the first place. Their blood group role is really just a side effect of being there and being variable. The actual biological function of the Rh proteins appears to involve gas transport across the red blood cell membrane. The Rh proteins belong to an ancient family of membrane proteins involved in ammonia transport, and they form a core complex that helps maintain the structural integrity of the red blood cell membrane.13PubMed Central. The Structure and Function of the Rh antigen Complex
A related protein called RhAG (Rh-associated glycoprotein) has been shown to facilitate the movement of ammonia and related gases across the red blood cell membrane, making it potentially an example of a gas channel in mammalian cells.14PubMed Central. Human Rhesus-associated glycoprotein mediates facilitated transport of NH(3) into red blood cells This may help red blood cells participate in clearing ammonia from the blood, though the full picture remains incomplete.
The importance of these proteins to red blood cell health is starkly illustrated by the very rare Rh-null phenotype, where a person lacks all Rh antigens entirely. Their red blood cells become misshapen (stomatocytes) and fragile, leading to chronic hemolytic anemia.15PubMed. A hypothesis of the stomatocytosis in individuals with the phenotype Rh(null) Rh-null blood is sometimes called “golden blood” because it can be transfused to virtually anyone, but the individuals who have it live with a lifelong blood disorder. Importantly, being Rh-negative is not the same as being Rh-null. Rh-negative people lack only the D antigen; they still express C/c and E/e antigens through the RHCE gene, and their red blood cells function normally.
Rh Status and Disease Risk
Beyond transfusion and pregnancy, researchers have explored whether Rh status might affect susceptibility to infections or other diseases. Most of these associations are weak or unconfirmed, but a few have attracted genuine interest.
During the COVID-19 pandemic, several studies found that Rh-negative individuals appeared to have a somewhat lower risk of SARS-CoV-2 infection. One analysis reported that Rh-negative people were about 21% less likely to test positive for the virus, and also showed a lower risk of severe illness and death.16PubMed Central. Relationship between blood type and outcomes following COVID-19 infection A review of the literature echoed this, noting that multiple studies found Rh-positive individuals were more likely to test positive and Rh-negative status appeared to have a protective effect against severe infection.17PubMed Central. Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review A separate study found a significant association between blood group type, Rh factor, and COVID-19 severity, with Rh-positive, blood group B individuals appearing most susceptible.18PubMed Central. Prediction of Covid-19 infection severity using ABO blood group types and Rh factor
The mechanism behind any such link is unclear, and these observational studies can’t rule out confounding factors. No one has proposed a convincing biological reason why the absence of D antigen on red blood cells would protect against a respiratory virus. These findings are worth knowing about but shouldn’t change anyone’s behavior.
Another widely discussed possibility is a connection between Rh status and susceptibility to Toxoplasma gondii, the parasite that causes toxoplasmosis. Some earlier individual studies suggested Rh-negative people responded differently to infection. However, a systematic review and meta-analysis found no significant association between Rh blood group and Toxoplasma seroprevalence. The prevalence of infection was essentially the same in Rh-positive and Rh-negative groups, at about 32% and 33% respectively.19PLOS ONE. Toxoplasma infection and Rhesus blood group system: A systematic review and meta-analysis
Rh Matching in Organ Transplantation
While Rh matching is treated as non-negotiable for blood transfusions, the rules are more relaxed for solid organ transplants. The organ allocation system currently does not take Rh blood group into account when matching donors and recipients.20Journal of Chest Surgery. Successful Heart Transplantation Despite Rhesus Blood Type Mismatch: A Case Report The concern with Rh-mismatched transplantation is mainly about downstream blood transfusions: an Rh-negative recipient of an Rh-positive organ might become sensitized to D and then have trouble receiving Rh-positive blood in the future. But the sensitization rate after solid organ transplantation appears to be lower than after blood transfusion, likely because organs carry far fewer red blood cells than a unit of blood does.
For bone marrow and stem cell transplants, the situation is more complex. The donor’s marrow will eventually produce new red blood cells with the donor’s Rh type, so an Rh-negative patient who receives marrow from an Rh-positive donor will gradually convert to Rh-positive. This is medically manageable but requires careful monitoring during the transition period.
Ancient Roots of the Rh System
The Rh genes are not unique to humans. Southern blot analysis using a human Rh-specific probe has detected Rh-related sequences in all great apes, Old World and New World monkeys, and in most non-primate animals tested.21PubMed. Investigation of the human Rh blood group system in nonhuman primates and other species with serologic and Southern blot analysis Analysis of gene sequences has shown that a specific genetic element is inserted in the same location in the Rh genes of humans, great apes, and both New and Old World monkeys, placing the shared ancestor of these Rh genes well before the primate lineages diverged.22Molecular Biology and Evolution. Rh Gene Evolution in Primates: Study of Intron Sequences
Interestingly, the companion gene Rh50 (which encodes the RhAG protein involved in ammonia transport) has evolved about twice as slowly as the Rh blood group gene in both primates and rodents.23PubMed. Conserved evolution of the Rh50 gene compared to its homologous Rh blood group gene This pattern suggests that the gas transport function of RhAG is tightly constrained by natural selection, while the D antigen itself, despite its medical importance to humans, has been freer to change over evolutionary time. The variation we now call “positive versus negative” is really just one chapter in a much longer evolutionary story about membrane transport proteins that happen to have become medically relevant.